Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.
AusPAR: Nuvaxovid
Australian Public Assessment Report
Device/Product Name
Nuvaxovid
Active ingredients
SARS-CoV-2 rS with Matrix M adjuvant (NVX-CoV2373)
AusPAR Date
Published
Sponsor
Submission Number
PM-2022-01431-1-2
Submission Type
Extension of indications
Decision
Approved for provisional registration